Originally published In Press as doi:10.1074/mcp.D600001-MCP200 on October 5, 2006.
Molecular & Cellular Proteomics 6:150-169, 2007.
© 2007 by The American Society for Biochemistry and Molecular Biology, Inc.
Dataset
Multivariable Difference Gel Electrophoresis and Mass Spectrometry
A Case Study on Transforming Growth Factor-ß and ERBB2 Signaling *,S
David B. Friedman , ,¶,
Shizhen E. Wang ,||,
Corbin W. Whitwell ,
Richard M. Caprioli , and
Carlos L. Arteaga ,||,**
From the Mass Spectrometry Research Center, Department of Biochemistry, Departments of ** Medicine and || Cancer Biology, and Breast Cancer Research Program, Vanderbilt-Ingram Comprehensive Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee 37232
Multivariable DIGE/MS was used to investigate proteins altered in expression and/or post-translational modification in response to activation of transforming growth factor (TGF)-ß receptors in MCF10A mammary epithelial cells overexpressing the HER2/Neu (ErbB2) oncogene. Proteome changes were monitored in response to exogenous TGF-ß over time (0, 8, 24, and 40 h), and proteins were resolved using medium range (pH 47) and narrow range (pH 5.36.5) isoelectric focusing combined with up to 2 mg of protein to allow inspection of lower abundance proteins. Triplicate samples were prepared independently and analyzed together across multiple DIGE gels using a pooled sample internal standard to quantify expression changes with statistical confidence. Unsupervised principle component analysis and hierarchical clustering of the individual DIGE proteome expression maps provided independent confirmation of distinct expression patterns from the individual experiments and demonstrated high reproducibility between replicate samples. Fifty-nine proteins (including some isoforms) that exhibited significant kinetic expression changes were identified using mass spectrometry and database interrogation and were mapped to existing biological networks involved in TGF-ß signaling. Several proteins with a potential role in breast cancer, such as maspin and cathepsin D, were identified as novel molecules associated with TGF-ß signaling.
¶ To whom correspondence should be addressed: Mass Spectrometry Research Center, Dept. of Biochemistry, Rm. 9114C, Medical Research Bldg. 3, Vanderbilt University, 465 21st Ave. S., Nashville, TN 37232-8575. Tel.: 615-343-7333; Fax: 615-343-8372; E-mail: david.friedman{at}vanderbilt.edu

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. J. Northey, J. Chmielecki, E. Ngan, C. Russo, M. G. Annis, W. J. Muller, and P. M. Siegel
Signaling through ShcA Is Required for Transforming Growth Factor {beta}- and Neu/ErbB-2-Induced Breast Cancer Cell Motility and Invasion
Mol. Cell. Biol.,
May 15, 2008;
28(10):
3162 - 3176.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. O. Meyrick, D. B. Friedman, D. D. Billheimer, J. D. Cogan, M. A. Prince, J. A. Phillips III, and J. E. Loyd
Proteomics of Transformed Lymphocytes from a Family with Familial Pulmonary Arterial Hypertension
Am. J. Respir. Crit. Care Med.,
January 1, 2008;
177(1):
99 - 107.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Wang, A. Narasanna, C. W. Whitell, F. Y. Wu, D. B. Friedman, and C. L. Arteaga
Convergence of p53 and Transforming Growth Factor beta (TGFbeta) Signaling on Activating Expression of the Tumor Suppressor Gene maspin in Mammary Epithelial Cells
J. Biol. Chem.,
February 23, 2007;
282(8):
5661 - 5669.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|